These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25899412)

  • 1. CT differentiation of poorly-differentiated gastric neuroendocrine tumours from well-differentiated neuroendocrine tumours and gastric adenocarcinomas.
    Kim SH; Kim SH; Kim MA; Shin CI; Han JK; Choi BI
    Eur Radiol; 2015 Jul; 25(7):1946-57. PubMed ID: 25899412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poorly-differentiated colorectal neuroendocrine tumour: CT differentiation from well-differentiated neuroendocrine tumour and poorly-differentiated adenocarcinomas.
    Kang JH; Kim SH; Han JK
    Eur Radiol; 2017 Sep; 27(9):3867-3876. PubMed ID: 28210802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome and CT differentiation of gallbladder neuroendocrine tumours from adenocarcinomas.
    Kim TH; Kim SH; Lee KB; Han JK
    Eur Radiol; 2017 Feb; 27(2):507-517. PubMed ID: 27225621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential and prognostic MRI features of gallbladder neuroendocrine tumors and adenocarcinomas.
    Bae JS; Kim SH; Yoo J; Kim H; Han JK
    Eur Radiol; 2020 May; 30(5):2890-2901. PubMed ID: 32025835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of poorly differentiated colorectal adenocarcinomas from well- or moderately differentiated colorectal adenocarcinomas at contrast-enhanced multidetector CT.
    Kim JE; Lee JM; Baek JH; Moon SK; Kim SH; Han JK; Choi BI
    Abdom Imaging; 2015 Jan; 40(1):1-10. PubMed ID: 24990513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT in advanced gastric carcinoma: is exploratory laparotomy avoidable?
    Triller J; Roder R; Stafford A; Schröder R
    Eur J Radiol; 1986 Aug; 6(3):181-6. PubMed ID: 3769940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydro-dynamic CT preoperative staging of gastric cancer: correlation with pathological findings. A prospective study of 107 cases.
    D'Elia F; Zingarelli A; Palli D; Grani M
    Eur Radiol; 2000; 10(12):1877-85. PubMed ID: 11305564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Added Diagnostic Value of
    Addeo P; Poncet G; Goichot B; Leclerc L; Brigand C; Mutter D; Romain B; Namer IJ; Bachellier P; Imperiale A
    J Gastrointest Surg; 2018 Apr; 22(4):722-730. PubMed ID: 29235002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spiral computed tomography and operative staging of gastric carcinoma: a comparison with histopathological staging.
    Davies J; Chalmers AG; Sue-Ling HM; May J; Miller GV; Martin IG; Johnston D
    Gut; 1997 Sep; 41(3):314-9. PubMed ID: 9378384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
    Yao J; Gan G; Farlow D; Laurence JM; Hollands M; Richardson A; Pleass HC; Lam VW
    ANZ J Surg; 2012 Mar; 82(3):140-4. PubMed ID: 22510123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
    Tang LH; Basturk O; Sue JJ; Klimstra DS
    Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of diagnostic criteria for liver metastases of adenocarcinomas and neuroendocrine tumours at conventional ultrasound, unenhanced power Doppler sonography and echo-enhanced ultrasound.
    Rickes S; Ocran KW; Gerstenhauer G; Neye H; Wermke W
    Dig Dis; 2004; 22(1):81-6. PubMed ID: 15292699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas.
    Tang LH; Untch BR; Reidy DL; O'Reilly E; Dhall D; Jih L; Basturk O; Allen PJ; Klimstra DS
    Clin Cancer Res; 2016 Feb; 22(4):1011-7. PubMed ID: 26482044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis.
    Poultsides GA; Huang LC; Chen Y; Visser BC; Pai RK; Jeffrey RB; Park WG; Chen AM; Kunz PL; Fisher GA; Norton JA
    Ann Surg Oncol; 2012 Jul; 19(7):2295-303. PubMed ID: 22396008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Imaging in the Follow-Up of Enteropancreatic Neuroendocrine Tumors: Clinical Usefulness and Indications.
    Merola E; Pavel ME; Panzuto F; Capurso G; Cicchese N; Rinke A; Gress TM; Iannicelli E; Prosperi D; Pizzichini P; Prasad V; Kump P; Lipp R; Partelli S; Falconi M; Wiedenmann B; Delle Fave G
    J Clin Endocrinol Metab; 2017 May; 102(5):1486-1494. PubMed ID: 28324047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duodenal neuroendocrine tumors: retrospective evaluation of CT imaging features and pattern of metastatic disease on dual-phase MDCT with pathologic correlation.
    Tsai SD; Kawamoto S; Wolfgang CL; Hruban RH; Fishman EK
    Abdom Imaging; 2015 Jun; 40(5):1121-30. PubMed ID: 25504375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited role of carbidopa-assisted
    Imperiale A; Averous G; Helali M; Taieb D; Pessaux P; Goichot B; Addeo P; Bachellier P
    Ann Nucl Med; 2019 Sep; 33(9):697-707. PubMed ID: 31214959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastroenteropancreatic neuroendocrine tumours (GEP-NET) - Imaging and staging.
    Baumann T; Rottenburger C; Nicolas G; Wild D
    Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):45-57. PubMed ID: 26971843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of CT findings between gastric cancer and gastric lymphoma].
    Fan WJ; Lu YC; Liu LZ; Shen JX; Xie CM; Li X; Zhang L
    Ai Zheng; 2008 May; 27(5):539-43. PubMed ID: 18479607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic enhanced CT: is there a difference between liver metastases of gastroenteropancreatic neuroendocrine tumor and adenocarcinoma.
    Cui Y; Li ZW; Li XT; Gao SY; Li Y; Li J; Zhu HC; Tang L; Cao K; Sun YS
    Oncotarget; 2017 Dec; 8(64):108146-108155. PubMed ID: 29296230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.